Xylometazoline-Betalek - instructions for use, dose, side effects, contraindications

Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, thus eliminating the edema and hyperemia of the nasal mucosa, restoring the nasal passages, facilitating nasal breathing.

The effect of the drug comes in a few minutes after its application and lasts up to 10 hours.

Pharmacokinetics:

With topical application, the drug is practically not absorbed, therefore its concentration in the blood plasma is very small (it is not determined by modern analytical methods).

Indications:

Applied in acute respiratory diseases with the phenomena of rhinitis (rhinitis), acute allergic rhinitis, sinusitis, with average otitis (as part of a combination therapy to reduce edema of the nasopharyngeal mucosa), to facilitate the conduct of a rhinoscopy.

Contraindications:

Hypersensitivity to xylometazoline, arterial hypertension, tachycardia, severe atherosclerosis, glaucoma,atrophic rhinitis, hyperthyroidism, surgical interventions on the meninges (in the anamnesis), pregnancy, children's age (up to 6 years - for 0.1% solution and for 0.05% solution - up to 2 years).

Do not use with monoamine oxidase (MAO) inhibitors and tricyclic antidepressants.

Carefully:Diabetes mellitus, lactation period, angina pectoris III-IV functional class, prostatic hyperplasia.

Dosing and Administration:

Adults and children over 6 years of age are administered 2-3 drops of 0.1% Xylometazoline-Betalec solution in each nasal passage 3-4 times a day.

Children from 2 to 6 years of age use a 0.05% solution of Xylometazoline-Betalec for 1-2 drops in each nasal passage 1-2 times a day. Do not use more than 3 times a day.

Do not apply the drug without interruption for more than 3-5 days.

Side effects:

With frequent and / or prolonged use - irritation and / or dryness of the mucous membrane of the nasopharynx, burning, tingling, sneezing, hypersecretion; rarely - swelling of the nasal mucosa, vomiting, headache, palpitations, increased blood pressure, insomnia, visual impairment, depression (with prolonged use of high doses).

Overdose:

Symptoms: increased side effects.

Treatment: symptomatic under the supervision of a doctor.

Interaction:

It is possible to enhance the systemic effect while using MAO inhibitors and tricyclic antidepressants.

Special instructions:

Do not use the drug for a long time, for example, with chronic rhinitis.

Effect on the ability to drive transp. cf. and fur:Xylometazoline, in dosages higher than recommended, may affect the ability to drive a vehicle or equipment.

Form release / dosage:

Nasal drops 0.05%, 0.1%.

Packaging:

For 10 ml in bottles-droppers polymer with a screw cap polymer coating with the control of the first opening.

Each bottle, together with the instructions for use, is placed in a pack of cardboard.

Storage conditions:

In the dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

Shelf life:

2 years.

Do not use after expiry date.

Terms of leave from pharmacies:Without recipe

Registration number:LSR-002284/07

Date of registration:17.08.2007

Expiration Date:Unlimited

The owner of the registration certificate:BETA-LEK, LLC BETA-LEK, LLC Russia

Manufacturer: & nbsp

BETA-LEK, LLC Russia

Information update date: & nbsp06.02.2018

Illustrated instructions

Instructions

Xylometazoline-Betalek (Xylometazoline-Betalek)